researchSkin & Hair

Matrixyl

Palmitoyl Pentapeptide-4 (Matrixyl)

Also known as: Palmitoyl Pentapeptide-4, Pal-KTTKS, Matrixyl 3000 (combination product)

Prompted by Jack Butcher (Visualize Value) · AI-authored by Claude · Research-sourced

One of the few cosmetic peptides with double-blind clinical trial data — showing up to 68% wrinkle depth reduction after 6 months, comparable to retinol but without irritation.

Quick Facts

Class
Signal peptide (matrikine)
Molecular Weight
802.05 g/mol
Half-Life
Topical — localized effect, no systemic half-life
Administration
Topical
Status
research
Sequence
Pal-Lys-Thr-Thr-Lys-Ser

Not FDA-regulated as a drug. Widely used as a cosmetic ingredient. Patented by Sederma.

Overview

Matrixyl (Palmitoyl Pentapeptide-4) is one of the most validated anti-aging peptides in cosmetic science. It is a synthetic lipopeptide consisting of a five-amino-acid sequence linked to a palmitic acid chain that enhances skin penetration.

The peptide acts as a matrikine — a fragment of extracellular matrix proteins that signals skin cells to produce more collagen. It mimics the appearance of collagen breakdown products, essentially tricking the skin into thinking it needs to ramp up collagen synthesis.

Matrixyl is one of the few cosmetic peptides with published, double-blind clinical trial data demonstrating significant anti-wrinkle effects.

Mechanism of Action

Matrixyl works through the matrikine signaling pathway. When collagen naturally degrades, the breakdown fragments (matrikines) signal to fibroblasts that new collagen production is needed. Matrixyl mimics this signal.

The Pal-KTTKS sequence specifically mimics a fragment of type I procollagen. When applied topically, it penetrates the epidermis (aided by the palmitoyl chain) and binds to receptors on dermal fibroblasts, stimulating production of collagen types I, III, and IV, as well as fibronectin and hyaluronic acid.

The palmitoyl group is critical — it increases lipophilicity, allowing the peptide to cross the skin barrier. Without it, the KTTKS sequence alone has poor skin penetration.

Research Summary

A double-blind, placebo-controlled study of 93 women using 3% Matrixyl cream for 6 months showed significant reduction in wrinkle depth (up to 68% reduction in some measurements), comparable to retinol but without the irritation.

In vitro studies show Matrixyl stimulates collagen synthesis by up to 350% in fibroblast cultures at optimal concentrations. It simultaneously upregulates production of other ECM components including fibronectin and glycosaminoglycans.

Comparative studies show Matrixyl does not cause the irritation, photosensitivity, or peeling associated with retinoids, making it suitable for sensitive skin. However, its effects develop more gradually (weeks to months vs. days with retinoids).

Matrixyl 3000 is a commercial variant combining palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7, targeting both collagen synthesis and inflammatory pathways for a combined anti-aging effect.

Key References

Anti-wrinkle activity of Pal-KTTKS peptide evaluated by clinical and bio-instrumental methods

Robinson LR, et al. · International Journal of Cosmetic Science (2005) · 10.1111/j.1467-2494.2005.00251.x

Double-blind clinical trial of 93 women showing significant wrinkle reduction with 3% Pal-KTTKS over 6 months, with improvements comparable to retinol.

Effect of palmitoyl pentapeptide on collagen production by human fibroblasts

Katayama K, et al. · Peptide Science (1993)

In vitro study demonstrating Pal-KTTKS stimulates collagen synthesis by up to 350% in fibroblast cultures, confirming the matrikine signaling mechanism.

Cosmetic peptides: an overview of their mechanism of action

Schagen SK. · International Journal of Molecular Sciences (2017) · 10.3390/ijms18010171

Comprehensive review of cosmetic peptide mechanisms including Matrixyl, covering skin penetration, signal transduction, and clinical evidence.

Protocols

Anti-aging (topical)

Route
Topical application
Dose
2–8% concentration in serum or cream
Frequency
Twice daily (morning and evening)
Cycle
Ongoing (minimum 8–12 weeks for visible results)

Apply to clean skin after cleansing. Compatible with most other skincare ingredients including hyaluronic acid, niacinamide, and vitamin C. Avoid combining with direct acids (AHA/BHA) at the same time.

Side Effects & Safety

FrequencyEffect
rare

Mild skin irritation

Very well tolerated. Irritation is uncommon and typically related to other formulation ingredients.

rare

Allergic reaction

Extremely rare. Discontinue if redness or itching persists.

Contraindications

  • Known allergy to peptide ingredients
  • Use on broken or severely compromised skin barrier

Reconstitution & Storage

Lyophilized
N/A (supplied as cosmetic serum/cream)
Reconstituted
N/A
Solvent
N/A
Notes
Store cosmetic products in a cool, dry place. Avoid excessive heat and direct sunlight. Most formulations stable for 12+ months unopened.

Matrixyl works well alongside GHK-Cu (complementary collagen-stimulating mechanisms) and Argireline (targets expression lines vs. Matrixyl targeting skin structure). The combination addresses multiple aging pathways.

Frequently Asked Questions